Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation.

Fu C, Li Q, Yang Y, Gu S, Zhao W, Yao X, Liu H

DOI: 10.1007/s11030-026-11680-6
Published: 2026 Dec
Container: Molecular diversity
Publisher: Not recorded
Open access: unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s11030-026-11680-6,
  title = {Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation.},
  author = {Fu C and Li Q and Yang Y and Gu S and Zhao W and Yao X and Liu H},
  year = {2026},
  journal = {Molecular diversity},
  doi = {10.1007/s11030-026-11680-6},
  url = {https://doi.org/10.1007/s11030-026-11680-6}
}

RIS

TY  - JOUR
TI  - Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation.
AU  - Fu C
AU  - Li Q
AU  - Yang Y
AU  - Gu S
AU  - Zhao W
AU  - Yao X
AU  - Liu H
PY  - 2026
JO  - Molecular diversity
DO  - 10.1007/s11030-026-11680-6
UR  - https://doi.org/10.1007/s11030-026-11680-6
ER  -

APA

C, F., Q, L., Y, Y., S, G., W, Z., X, Y., & H, L. (2026). Discovery of novel RIPK3 inhibitors by virtual screening and bioactivity evaluation.. Molecular diversity. https://doi.org/10.1007/s11030-026-11680-6

Source records

pubmed · retrieved 2026-11-10T11:36:27.029Z